PIN28 Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan

Simple item page
dc.contributor.authorAlmadiyeva, A.
dc.contributor.authorKostyuk, A.
dc.contributor.authorNurgozhin, T.
dc.creatorA., Almadiyeva
dc.date.accessioned2017-12-14T08:54:47Z
dc.date.available2017-12-14T08:54:47Z
dc.date.issued2013-11-01
dc.description.abstractCurrently, 23 thousand people (registered) are suffering from Hepatitis C in Germany (more 60% genotype 1). TThe licensing of direct-acting antivirals heralds a new era in the treatment of hepatitis C virus (HCV) genotype 1. Clinical studies showed a significant increase in sustained virological response rates from 38-46% to 63-79%. This study was to evaluate the cost-effectiveness of newly introduced triple therapy with Telaprevir (TVR+PR) compared to dual therapy (PR) for the treatment of genotype 1 hepatitis C virus (HCV) infection in previously untreated patients.
dc.identifierDOI:10.1016/j.jval.2013.08.138
dc.identifier.citationA. Almadiyeva, A. Kostyuk, T. Nurgozhin, PIN28 - Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan, In Value in Health, Volume 16, Issue 7, 2013, Page A345
dc.identifier.issn10983015
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1098301513020433
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2898
dc.relation.ispartofValue in Health
dc.rights.licenseCopyright © 2013 Published by Elsevier Inc.
dc.titlePIN28 Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan
dc.typeArticle
dcterms.publisherValue in Health
elsevier.aggregationtypeJournal
elsevier.coverdate2013-11-01
elsevier.coverdisplaydateNovember 2013
elsevier.identifier.doi10.1016/j.jval.2013.08.138
elsevier.identifier.eid1-s2.0-S1098301513020433
elsevier.identifier.piiS1098-3015(13)02043-3
elsevier.issue.identifier7
elsevier.issue.nameISPOR 16th Annual European Congress and 4th Latin America Conference Research Abstracts
elsevier.openaccess1
elsevier.openaccessarticletrue
elsevier.openaccessuserlicensehttp://www.elsevier.com/open-access/userlicense/1.0/
elsevier.openarchivearticletrue
elsevier.startingpageA345
elsevier.volume16

Files

Collections

Articles